RHEA DOUGLAS: Open Payments
NPI 1023247210 · DECATUR, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$6,426 in 77 payments from 19 companies in 2025. Trend: 2023 $1,538 · 2024 $3,206 · 2025 $6,426
Speaker / faculty: $2,632Food & beverage: $2,594Consulting: $1,200
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 13 | $3,137 |
| Arcutis Biotherapeutics, Inc. | 5 | $1,272 |
| UCB, Inc. | 7 | $292 |
| Organon LLC | 6 | $289 |
| Novartis Pharmaceuticals Corporation | 9 | $278 |
| ABBVIE INC. | 8 | $195 |
| Galderma Laboratories, L.P. | 4 | $160 |
| Botanix SB Inc | 2 | $155 |
| Janssen Scientific Affairs, LLC | 1 | $136 |
| LEO Pharma Inc. | 5 | $135 |
Products named: DUPIXENT, Zoryve, Bimzelx, VTAMA, TREMFYA, NEMLUVIO, SOFDRA, SKYRIZI.
Industry payments across GA — which companies pay providers there.
